OVOL1 and Alzheimer disease: To gain further insight into the immunological responses of the skin to Ovol1 deletion-induced AD-associated epidermal dysregulation, we conducted comprehensive immune cell profiling of control and SSKO skin during both homeostasis and AD-like inflammation.